Novo Nordisk A/S (NVO)
46.94
+0.20
(+0.44%)
USD |
NYSE |
Aug 24, 16:00
47.05
+0.10
(+0.22%)
After-Hours: 20:00
Novo Nordisk Total Assets (Quarterly) : 91.00B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.00B |
| March 31, 2026 | 86.23B |
| December 31, 2025 | 85.37B |
| September 30, 2025 | 80.64B |
| June 30, 2025 | 75.86B |
| March 31, 2025 | 70.82B |
| December 31, 2024 | 64.68B |
| September 30, 2024 | 59.50B |
| June 30, 2024 | 53.09B |
| March 31, 2024 | 43.28B |
| December 31, 2023 | 46.60B |
| September 30, 2023 | 42.61B |
| June 30, 2023 | 41.14B |
| March 31, 2023 | 36.47B |
| December 31, 2022 | 34.62B |
| September 30, 2022 | 31.99B |
| June 30, 2022 | 30.78B |
| March 31, 2022 | 29.49B |
| December 31, 2021 | 29.74B |
| September 30, 2021 | 27.13B |
| June 30, 2021 | 25.21B |
| March 31, 2021 | 22.34B |
| December 31, 2020 | 23.82B |
| September 30, 2020 | 22.05B |
| June 30, 2020 | 20.51B |
| Date | Value |
|---|---|
| March 31, 2020 | 18.56B |
| December 31, 2019 | 18.87B |
| September 30, 2019 | 18.24B |
| June 30, 2019 | 17.99B |
| March 31, 2019 | 16.57B |
| December 31, 2018 | 16.97B |
| September 30, 2018 | 15.87B |
| June 30, 2018 | 16.18B |
| March 31, 2018 | 15.44B |
| December 31, 2017 | 16.51B |
| September 30, 2017 | 15.55B |
| June 30, 2017 | 15.01B |
| March 31, 2017 | 13.55B |
| December 31, 2016 | 13.84B |
| September 30, 2016 | 13.18B |
| June 30, 2016 | 13.18B |
| March 31, 2016 | 12.60B |
| December 31, 2015 | 13.36B |
| September 30, 2015 | 12.75B |
| June 30, 2015 | 12.14B |
| March 31, 2015 | 11.14B |
| December 31, 2014 | 12.52B |
| September 30, 2014 | 12.10B |
| June 30, 2014 | 11.69B |
| March 31, 2014 | 11.67B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 114.02B |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| Novartis AG | 122.03B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 57.15B |
| Shareholders Equity (Quarterly) | 33.84B |
| Debt to Equity Ratio | 0.6333 |
| Current Ratio | 0.8729 |
| Net Debt Paydown Yield | -0.53% |